Verici Dx plc (LON:VRCI – Get Free Report) dropped 18.2% on Thursday . The stock traded as low as GBX 2.25 ($0.03) and last traded at GBX 2.25 ($0.03). Approximately 624,617 shares were traded during trading, a decline of 29% from the average daily volume of 884,824 shares. The stock had previously closed at GBX 2.75 ($0.04).
Verici Dx Trading Down 20.7 %
The company has a current ratio of 4.54, a quick ratio of 8.49 and a debt-to-equity ratio of 4.64. The stock has a market capitalization of £6.62 million, a PE ratio of -1.26 and a beta of 1.59. The stock has a 50 day moving average price of GBX 3.24 and a 200-day moving average price of GBX 3.90.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- NYSE Stocks Give Investors a Variety of Quality Options
- Energy Transfer: Powering Data With Dividends and Diversification
- Industrial Products Stocks Investing
- Qualcomm Stock Is Coiling for a Breakout
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
